Efficacy and Safety of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis and Multiple Comorbidities

被引：0

作者：

Glaspole, I. ^{[1
,2
]}

Bonella, F. ^{[3
]}

Bargagli, E. ^{[4
]}

Glassberg, M. K. ^{[5
]}

Caro, F. ^{[6
]}

Stansen, W. ^{[7
]}

Quaresma, M. ^{[8
]}

Orsatti, L. ^{[8
]}

Bendstrup, E. ^{[9
]}

机构：

[1] Alfred Hlth, Dept Allergy Immunol & Resp Med, Melbourne, Vic, Australia

[2] Monash Univ, Dept Med, Melbourne, Vic, Australia

[3] Duisburg Essen Univ, Interstitial & Rare Lung Dis Unit, Ruhrlandklin, Univ Hosp, Essen, Germany

[4] Siena Univ Hosp, Sect Resp Dis & Lung Transplantat, Dept Clin Med & Neurosci, Siena, Italy

[5] Univ Miami, Miller Sch Med, Miami, FL 33136 USA

[6] Maria Ferrer Hosp, Buenos Aires, DF, Argentina

[7] Boehringer Ingelheim GmbH & Co KG, Ingelheim, Germany

[8] Boehringer Ingelheim Int GmbH, Ingelheim, Germany

[9] Aarhus Univ Hosp, Dept Resp Dis & Allergy, Aarhus, Denmark

来源：

关键词：

D O I：

暂无

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

A4549

引用

页数：2